Point72 Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.2M Buy
2,003,000
+484,800
+32% +$12.9M 0.07% 323
2025
Q4
$37.8M Buy
1,518,200
+316,700
+26% +$7.99M 0.04% 540
2025
Q3
$30.6M Sell
1,201,500
-18,400
-2% -$454K 0.05% 400
2025
Q2
$29.6M Buy
1,219,900
+112,000
+10% +$2.61M 0.06% 373
2025
Q1
$28.1M Buy
1,107,900
+420,300
+61% +$11M 0.06% 355
2024
Q4
$18.2M Buy
687,600
+78,300
+13% +$2.12M 0.04% 484
2024
Q3
$17.6M Sell
609,300
-236,200
-28% -$6.89M 0.04% 456
2024
Q2
$23.7M Sell
845,500
-40,900
-5% -$1.13M 0.06% 360
2024
Q1
$24.6M Buy
+886,400
New +$24.6M 0.06% 388
2020
Q3
Sell
-316,200
Closed -$9.81M 1054
2020
Q2
$9.81M Buy
+316,200
New +$10.7M 0.06% 344
2015
Q4
Sell
-2,318,800
Closed -$69.1M 798
2015
Q3
$69.1M Sell
2,318,800
-316,200
-12% -$10.1M 0.54% 33
2015
Q2
$83.8M Sell
2,635,000
-2,635,000
-50% -$85.9M 0.58% 35
2015
Q1
$174M Buy
+5,270,000
New +$168M 1.19% 6

Other funds holding PFE

Point72 Asset Management's PFE Position: Q1 2026 in Review

Point72 Asset Management increased its Pfizer (PFE) stake by 32% in Q1 2026, buying an estimated $28.2M and bringing the position to 4,365,063 shares worth $123M. The position accounts for 0.16% of the portfolio, ranked #133.

Point72 Asset Management first reported a position in PFE in Q3 2014 and has held it in 12 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Point72 Asset Management held 4,365,063 shares of Pfizer worth $123M as of Q1 2026.
  • Point72 Asset Management bought 1,059,371 Pfizer shares in Q1 2026, an estimated $28.2M.
  • Pfizer made up 0.16% of Point72 Asset Management's portfolio in Q1 2026, its #133 holding.
  • Point72 Asset Management first reported a position in Pfizer in Q3 2014 and has held it in 12 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.